DE68920439D1 - Methode für die änderung der bindung eines zelladhäsionrezeptors. - Google Patents

Methode für die änderung der bindung eines zelladhäsionrezeptors.

Info

Publication number
DE68920439D1
DE68920439D1 DE68920439T DE68920439T DE68920439D1 DE 68920439 D1 DE68920439 D1 DE 68920439D1 DE 68920439 T DE68920439 T DE 68920439T DE 68920439 T DE68920439 T DE 68920439T DE 68920439 D1 DE68920439 D1 DE 68920439D1
Authority
DE
Germany
Prior art keywords
binding
increase
receptors
cations
changing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68920439T
Other languages
English (en)
Other versions
DE68920439T2 (de
Inventor
Erkki Ruoslahti
James Gailit
Kurt Gehlsen
Aarno Hautanen
Michael Pierschbacher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanford Burnham Prebys Medical Discovery Institute
Original Assignee
Sanford Burnham Prebys Medical Discovery Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanford Burnham Prebys Medical Discovery Institute filed Critical Sanford Burnham Prebys Medical Discovery Institute
Publication of DE68920439D1 publication Critical patent/DE68920439D1/de
Application granted granted Critical
Publication of DE68920439T2 publication Critical patent/DE68920439T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/7055—Integrin beta1-subunit-containing molecules, e.g. CD29, CD49
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/244—Lanthanides; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE68920439T 1988-09-14 1989-09-13 Methode für die änderung der bindung eines zelladhäsionrezeptors. Expired - Fee Related DE68920439T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24470188A 1988-09-14 1988-09-14
PCT/US1989/003979 WO1990002556A1 (en) 1988-09-14 1989-09-13 Methods for modifying the binding of cell adhesion receptors

Publications (2)

Publication Number Publication Date
DE68920439D1 true DE68920439D1 (de) 1995-02-16
DE68920439T2 DE68920439T2 (de) 1995-05-11

Family

ID=22923789

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68920439T Expired - Fee Related DE68920439T2 (de) 1988-09-14 1989-09-13 Methode für die änderung der bindung eines zelladhäsionrezeptors.

Country Status (5)

Country Link
EP (1) EP0435946B1 (de)
JP (1) JPH04501715A (de)
AT (1) ATE116548T1 (de)
DE (1) DE68920439T2 (de)
WO (1) WO1990002556A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3901458A1 (de) * 1989-01-19 1990-07-26 Behringwerke Ag Verwendung von zwei- oder dreiwertigen kationen in immunchemischen tests
US6572896B1 (en) * 1998-01-30 2003-06-03 A.T. Still University Of Health Sciences Methods for inhibiting cell motility
EP1177291A2 (de) * 1999-04-30 2002-02-06 Biostratum, Inc. Laminin 8 und methoden zur verwendung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4614517A (en) * 1982-08-04 1986-09-30 La Jolla Cancer Research Foundation Tetrapeptide
US4578079A (en) * 1982-08-04 1986-03-25 La Jolla Cancer Research Foundation Tetrapeptide
US4683291A (en) * 1985-10-28 1987-07-28 Scripps Clinic And Research Foundation Platelet binding inhibitors

Also Published As

Publication number Publication date
ATE116548T1 (de) 1995-01-15
JPH04501715A (ja) 1992-03-26
EP0435946B1 (de) 1995-01-04
WO1990002556A1 (en) 1990-03-22
DE68920439T2 (de) 1995-05-11
EP0435946A1 (de) 1991-07-10

Similar Documents

Publication Publication Date Title
Miles et al. Promotion of cell adhesion by single-stranded and triple-helical peptide models of basement membrane collagen alpha 1 (IV) 531-543. Evidence for conformationally dependent and conformationally independent type IV collagen cell adhesion sites.
FI102017B (fi) Elektrokemoluminoivat analyysimenetelmät
EP0157643A3 (de) Antikörper zum menschlichen Interleukin-2, eingeführt durch synthetische Polypeptide
DE3684741D1 (de) Quadratfarbstoffkonjugat, dessen herstellungsverfahren und dessen verwendung bei testverfahren sowie testsaetze.
DE69131556D1 (de) Zusammensetzung zum verbinden und abdichten von geweben und verfahren zu ihrer verwendung
DE3382495D1 (de) Protein-a material und dessen herstellung.
ATE123810T1 (de) Alpha-subeinheit des lfa-1-leukocyt-adhäsions- rezeptors.
US5766857A (en) Isolation and use of fibronectin receptor
PT1019420E (pt) Metodos para a producao de ligandos baseados em platina para ligacao entre marcadores e moleculas bio-orgaicas na marcacao de moleculas bio-organicas com o fim de detectar substancias biologicas de interesse e conjuntos ("kits") de ensaios de diagnosticos
ATE120550T1 (de) Verfahren zum nachweis von malignen erkrankungen.
Breit et al. The effect of alpha 1 antitrypsin on the proliferative response of human peripheral blood lymphocytes.
DE68920439D1 (de) Methode für die änderung der bindung eines zelladhäsionrezeptors.
DE69007006D1 (de) Ligand enthaltendes Medium für chromatographische Trennung, Verfahren zur dessen Herstellung und dessen Verwendung zur Isolierung von synthetischen oder natürlichen Molekülen von einer Fluidmischung.
ATE139260T1 (de) Diagnostische gene zum nachweis von toxoplasmose
DE69840895D1 (de) Monospezifische antikörper gegen fibrinogen und fibrinopeptide b
JPS6447391A (en) Monoclonal antibody and use thereof
AR016681A1 (es) Deplecion de celulas th2; composiciones; metodos
DE69304331D1 (de) Verfahren zur detektion neoplastischer erkrankungen
ATE144791T1 (de) Innerhalb des alpha-locus gelegenes t-zell- rezeptor-gen und dna-konstruktionen
DE69930843D1 (de) Verfahren zum bestimmen von autoantikörpern
Ryrie et al. Transmembrane organization of individual polypeptides of photosystem I complex and the light-harvesting complex of photosystem II of thylakoid membranes
DE69505365D1 (de) Immunologisches verfahren zum nachweis von glykosaminoglykan-aktiviertem antithrombin iii; die entsprechenden monoklonalen antikörper und deren herstellung
DE3580524D1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
DE3871530D1 (de) Vorrichtung zum kultivieren von ruhenden zellen in einem bioreaktor.
ATE110853T1 (de) Immuntestverfahren für zelluläres eiweiss.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee